A Phase 2 Multicenter, Randomized, Placebo- and Active-Comparator-Controlled, Dose-Ranging Trial to Evaluate CNTO 1959 for the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis (X-PLORE)
Read time: 2 mins
Last updated:1st Nov 2011
The purpose of this study is to evaluate the efficacy and safety of CNTO 1959 in the treatment of patients with moderate to severe plaque psoriasis.
|Date last updated at source||2016-03-29|
|Study start date||2011-11-01|
|Estimated primary completion date||2013-08-01|